Childhood cancers: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 5,947 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

  NCT06222203· National Cancer Institute (NCI)· Source

• A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

  NCT05621291· National Cancer Institute (NCI)· Source

• Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

  NCT05237986· National Cancer Institute (NCI)· Source

• Dabrafenib and/or Trametinib Rollover Study

  NCT03340506· Novartis Pharmaceuticals· Source

• Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

  NCT07524530· National Cancer Institute (NCI)· Source

• Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

  NCT00050752· National Cancer Institute (NCI)· Source

• Rare Tumors and Cancer Predisposition in Individuals and Families

  NCT05350761· National Cancer Institute (NCI)· Source

• Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

  NCT06303193· National Cancer Institute (NCI)· Source

• Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

  NCT03919071· National Cancer Institute (NCI)· Source

• Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

  NCT07437963· National Cancer Institute (NCI)· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 36
• Organoids 15
• Mendelian Randomization Analysis 12
• CRISPR-Cas Systems 15
• Gene Expression Profiling 122
• Sequence Analysis, RNA 20
• Whole Genome Sequencing 22
• Exome Sequencing 30
• Proteomics 50
• Metabolomics 24
• Mass Spectrometry 12
• Flow Cytometry 86
• Immunohistochemistry 196
• Liquid Biopsy 24
• Circulating Tumor DNA 15
• Xenograft Model Antitumor Assays 133
• Positron-Emission Tomography 52
• Magnetic Resonance Imaging 512
• Machine Learning 65
• Deep Learning 24
• Cohort Studies 327
• Genome-Wide Association Study 22

See which targets of this disease your abstract mentions, and go to the people working on them.